Remove 2018 Remove Chronic Pain Remove Clinical Trials Remove Data
article thumbnail

Press Release: Global Wellness Signs Definitive Agreement with Cannvalate Australia

Cannabis Law Report

Enters into the Chronic Pain Market with Psychedelics. This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. Global Wellness Strategies Inc. ( billion in 2030.

article thumbnail

Medical cannabis studies offer hope to opioid users

Healer

That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Explore the Latest Studies for Veteran PTSD Research

Veriheal

According to data on Healthy Place , treatment for PTSD is typically accommodated for the general public, of who the vast majority have not experienced military combat. A 2020 study reported that the top conditions reported amongst veterans include chronic pain , sleep problems , anxiety , and depression.

Treatment 104
article thumbnail

UK: David Hardstaff And John Binns Write For Open Access Government Exploring Shifting Sands In The UK CBD Industry

Cannabis Law Report

Medicinal cannabis products have been available since 2018. Cannabis-based products for medicinal use, or “CBPMs”, have been available for prescription in the UK since 2018; however, access is strictly limited through existing and bespoke regulatory controls. That position could dramatically change.

Access 52
article thumbnail

MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation

Cannabis Law Report

MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. 1 Data published by Research and Markets, March 2018. Dr. Chapman Bio.

article thumbnail

Bogged down by skyrocketing medical cannabis bills? This cannabis company is developing a Health Canada approved solution

Weedistry

to June 2018, Health Canada reported there were 2,066 apparent opioid-related deaths; 94 percent of these were accidental. The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. “The Can medical cannabis be the solution?

article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .